EGFR Mutation and 11q13 Amplification Are Potential Predictive Biomarkers for Immunotherapy in Head and Neck Squamous Cell Carcinoma

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is one of the most common malignant cancers. The treatment of HNSCC remains challenging despite recent progress in targeted therapies and immunotherapy. Research on predictive biomarkers in clinical settings is urgently needed. METHODS: Next-...

Descripción completa

Detalles Bibliográficos
Autores principales: Dou, Shengjin, Zhang, Lin, Wang, Chong, Yao, Yanli, Jiang, Wen, Ye, Lulu, Li, Jiang, Wu, Sicheng, Sun, Debin, Gong, Xiaoli, Li, Rongrong, Zhu, Guopei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965897/
https://www.ncbi.nlm.nih.gov/pubmed/35371031
http://dx.doi.org/10.3389/fimmu.2022.813732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965897/
https://www.ncbi.nlm.nih.gov/pubmed/35371031
http://dx.doi.org/10.3389/fimmu.2022.813732

Ejemplares similares